Brain development and the genetics of brain development

Neurologic Clinics

Volumn 20, Issue 4, 2002, Pages 917-939

  Clark, Gary D ^a  

^a Cain Foundation Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGYRIA; ALEXANDER DISEASE; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CLINICAL FEATURE; DATA BASE; FAMILY; GENE DISRUPTION; HOLOPROSENCEPHALY; HUMAN; MICROCEPHALY; MICROGYRIA; NEURAL TUBE; ONLINE SYSTEM; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SCHIZENCEPHALY; SEPTOOPTIC DYSPLASIA;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; BRAIN DISEASES; CELL ADHESION MOLECULES, NEURONAL; CHILD; CONTRACTILE PROTEINS; DEVELOPMENTAL DISABILITIES; EXTRACELLULAR MATRIX PROTEINS; FETAL DISEASES; HOMEODOMAIN PROTEINS; HUMANS; MAGNETIC RESONANCE IMAGING; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; POINT MUTATION; PROTEINS; SERINE ENDOPEPTIDASES;

EID: 0036830289     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(02)00024-5     Document Type: Review

References (96)

1. Brockes J. Reading the retinoid signals. Nature 1990;345(6278):766-8.
2. Lemire R, Loeser J, Leech R, et al. Normal and Abnormal Development of the Human Nervous System. New York: Harper & Row; 1975.
3. Scotting PJ, Rex M. Transcription factors in early development of the central nervous system. Neuropathol Appl Neurobiol 1996;22:469-81.
4. Thaller C, Eichele G. Isolation of 3,4-didehrdroretinic acid, a novel morphogenetic signal in the chick wing bud. Nature 1990;345(6278):815-22.
5. Geelan JA, Langman J. Closure of the neural tube in the cephalic region of the mouse embryo. Anat Rec 1977;189:625-40.
6. Brunelli S, Faiella A, Capra V, et al. Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet 1996;12:94-6.
7. Hillburger AC, Willis JK, Bouldin E, et al. Familial schizencephaly. Brain Dev 1993;15:234-6.
8. Barkovich AJ, Kjos BO. Schizencephaly: Correlation of clinical findings with MR characteristics. Am J Neuroradiol 1992;13:85-94.
9. Barth P. Disorders of neuronal migration. Can J Neurol Sci 1987;14:1-16.
10. Barkovich A, Chuang S, Norman D. MR of neuronal migration anomalies. Am J Neuroradiol 1987;8:1009-17.
11. Barkovich A, Kjos B. Schizencephaly: Correlation of clinical findings with MR characteristics. Am J Neuroradiol 1992;13:85-94.
12. Brodtkorb E, Nilsen G, Smevik O, et al. Epilepsy and anomalies of neuronal migration: MRI and clinical aspects. Acta Neurol Scand 1992;86:24-32.
13. Kuzniecky R. Magnetic resonance imaging in developmental disorders of the cerebral cortex. Epilepsia 1994;35(Suppl 6):S44-56.
14. Aicardi J, Goutieres F. The syndrome of absence of the septum pellucidum with porencephalies and other developmental defects. Neuropediatrics 1981;12:319-29.
15. Leech R, Shuman R. Midline telencephalic dysgenesis: Report of three cases. J Child Neurol 1986;1:224-32.
16. Smith J. Hedgehog, the floor plate, and the zone of polarizing activity. Cell 1994;76:193-6.
17. Helms JA, Kim CH, Hu D, et al. Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid. Dev Biol 1997;187:25-35.
18. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-71.
19. Stone DM, Hynes M, Armanini M, et al. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 1996;384:129-34.
20. Conlon RA. Retinoic acid and pattern formation in vertebrates. Trends Genet 1995;11:314-9.
21. Nakagawa Y, Kaneko T, Ogura T, et al. Roles of cell-autonomous mechanisms for differential expression of region-specific transcription factors in neuroepithelial cells. Development 1996;122:2449-64.
22. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985;313:837-41.
23. Barkovich AJ. Imaging aspects of static encephalopathies. In Miller G, Ramer JC, editors. Static Encephalopathies of Infancy and Childhood. New York: Raven Press; 1992. p. 45-94.
24. Dobyns WB. Cerebral dysgenesis: Causes and consequences. In Miller G, Ramer JC, editors. Static Encephalopathies of Infancy and Childhood. New York: Raven Press; 1992. p. 235-48.
25. Nyberg DA, Mack LA, Bronstein A, et al. Holoprosencephaly: Prenatal sonographic diagnosis. Am J Radiol 1987;149:1051-8.
26. Souza JP, Siebert JR, Beckwith JB. An anatomic comparison of cebocephaly and ethmocephaly. Teratology 1990;42:347-57.
27. Romshe CA, Sotos JF. Hypothalamic-pituitary dysfunction in siblings of patients with holoprosencephaly. J Pediatr 1973;83:1088-90.
28. Barr M, Hansen JW, Currey K, et al. Holoprosencephaly in infants of diabetic mothers. J Pediatr 1983;102:565-8.
29. Cohen MMJ, Lemire RJ. Syndromes with cephaloceles. Teratology 1983;25:161-72.
30. Muenke M. Clinical, cytogenetic, and molecular approaches to the genetic heterogeneity of holoprosencephaly. Am J Med Genet 1989;34:237-45.
31. Heussler HS, Suri M, Young ID, et al. Extreme variability of expression of a Sonic Hedgehog mutation: Attention difficulties and holoprosencephaly. Arch Dis Child 2002;86:293-6.
32. Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic hedgehog gene cause holoprosencephaly. Nat Genet 1996;14:357-60.
33. Ming JE, Kaupas ME, Roessler E, et al. Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum Genet 2002;110:297-301.
34. Wallis D, Muenke M. Mutations in holoprosencephaly. Hum Mutat 2000;16:99-108.
35. Brickman JM, Clements M, Tyrell R, et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001;128:5189-99.
36. Ouvier R, Billson F. Optic nerve hypoplasia: A review. J Child Neurol 1986;1:181-8.
37. Costin G, Murphree AL. Hypothalamic-pituitary function in children with optic nerve hypoplasia. Am J Dis Child 1985;139:249-54.
38. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19:125-33.
39. Patel H, Tze WJ, Crichton JU, et al. Optic nerve hypoplasia with hypopituitarism: Septooptic dysplasia with hypopituitarism. Am J Dis Child 1975;129:175-80.
40. Caviness VS, Takahashi T. Proliferative events in the cerebral ventricular zone. Brain Dev 1995;17:159-63.
41. Ross ME. Cell division and the nervous system: Regulating the cycle from neural differentiation to death. Trends Neurosci 1996;19:62-8.
42. Matsushime H, Quelle DE, Shurtleff SA, et al. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 1994;14:2066-76.
43. Meyerson M, Harlow M. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994;14:2077-86.
44. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8.
45. Sherr CJ. G1 phase progression: Cycling on cue. Cell 1994;79:551-5.
46. Clarke PG. Developmental cell death: Morphological diversity and multiple mechanisms. Anat Embryol (Berl) 1990;181:195-213.
47. Schwartz LM, Smith SW, Jones MEE, et al. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 1993;90:980-4.
48. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
49. Warkany J, Lemire RJ, Cohen MM. Mental Retardation and Congenital Malformations of the Central Nervous System. Chicago: Year Book Medical; 1981. p. 13-40.
50. Haslam R, Smith DW. Autosomal dominant microcephaly. J Pediatr 1979;95:701-5.
51. Optiz JM, Holt MC. Microcephaly: General considerations and aids to nosology. J Craniofac Genet Dev Biol 1990;10:175-204.
52. Renier WO, Gabreels FJM, Jasper TWJ, et al. An x-linked syndrome with microcephaly, severe mental retardation, spasticity, epilepsy and deafness. J Ment Defic Res 1982;26:27-40.
53. Evrard P, De Saint-Georges P, Kadhim H, et al. Pathology of prenatal encephalopathies. In French JH, Harel S, Casaer P, editors. Child Neurology and Development Disabilities. Baltimore: PH Books; 1989. p. 153-76.
54. Lenke RR, Levy HL. Maternal phenylketonuria and hyperphenylalaninemia. N Engl J Med 1980;303:1202-8.
55. Yamazaki JN, Schull WJ. Perinatal loss and neurological abnormalities among children of the atomic bomb. Nagasaki and Hiroshima revisited, 1949 to 1989. JAMA 1990;264:605-9.
56. Barkovich AJ, Chuang SH. Unilateral megalencephaly: Correlation of MR imaging and pathologic characteristics. Am J Neuroradiol 1990;11:523-31.
57. DeRosa MJ, Secor DL, Barsom M, et al. Neuropathologic findings in surgically treated hemimegalencephaly: Immunohisotchemical, morphometric and ultrastructural study. Acta Neuropathol (Berl) 1992;84:250-60.
58. Renowden S, Squier M. Unusual magnetic resonance and neuropathological findings in hemi-megalencephaly: Report of a case following hemispherectomy. Dev Med Child Neurol 1994;36:357-69.
59. Rintahaka P, Chugani H, Messa C, et al. Hemimegalencephaly: Evaluation with positron emission tomography. Pediatr Neurol 1993;9:21-8.
60. DeMyer W. Megalencephaly in children. Clinical syndromes, genetic patterns and differential diagnosis from other cases of megalencephaly. Neurology 1972;22:634-43.
61. DeMyer W. Megalencephaly: Types, clinical syndromes and management. Pediatr Neurol 1986;2:321-8.
62. Hager BC, Dyme IZ, Guertin SR, et al. Linear nevus sebaceous syndrome: Megalencephaly and heterotopic gray matter. Pediatr Neurol 1991;7:45-9.
63. Pavone L, Curatolo P, Rizzo R, et al. Epidermal nevus syndrome: A neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Neurology 1991;41:266-71.
64. Jelinek JE, Bart RS, Schiff GM. Hypomelanosis of Ito ("incontinentia pigmenti achromians"): Report of three cases and review of the literature. Arch Dermatol 1973;107:596-601.
65. Haines JL, Short MP, Kwiatkowski DJ, et al. Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity. Am J Hum Genet 1991;49:764-72.
66. Ogawa M, Miyata T, Nakajima K, et al. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neurons 1995;14:899-912.
67. Sidman R, Rakic P. Neuronal migration with special reference to developing human brain, a review. Brain Res 1973;62:1-35.
68. Aicardi J. The place of neuronal migration abnormalities in child neurology. Can J Neurol Sci 1994;21:185-93.
69. Angevine J, Sidman R. Autoradiographic study of cell migration during histogenesis of cerebral cortex of the mouse. Nature 1961;192:766-8.
70. D'Arcangelo G, Miao GG, Chen S-C, et al. A protein related to extracellular matrix proteins deleted in the mouse reeler. Nature 1995;374:719-23.
71. D'Arcangelo G, Miao GG, Curran T. Detection of the reelin breakpoint in reeler mice. Brain Res Mol Brain Res 1996;39:234-6.
72. Hirotsune S, Takahara T, Sasaki N, et al. The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat Genet 1995;10:77-83.
73. Rommsdorff M, Gotthardt M, Hiesberger T, et al. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999;97:689-701.
74. Ledbetter SA, Kuwano A, Dobyns WB, et al. Microdeletions of chromosome 17p13 as a cause of isolated lissencephaly. Am J Hum Genet 1992;50:182-9.
75. Sharief N, Craze J, Summers D, et al. Miller-Dieker syndrome with ring chromosome 17. Arch Dis Child 1991;66:710-2.
76. Greenberg F, Stratton R, Lockhart L, et al. Familial Miller-Dieker syndrome associated with pericentric inversion of chromosome 17. Am J Med Genet 1986;23:853-9.
77. Dobyns WB, Stratton RF, Parke JT, et al. Miller-Dieker syndrome: Lissencephaly and monosomy 17p. J Pediatr 1983;102:552-8.
78. Chong SS, Pack SD, Roschke AV, et al. A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum Mol Genet 1997;6:147-55.
79. Lo Nigro C, Chong SS, Smith ACM, et al. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet 1997;6:157-64.
80. Pilz DT, Matsumoto N, Minnerath S, et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet 1998;7:2029-37.
81. Gleeson JG, Luo RF, Grant PE, et al. Genetic and neuroradiological heterogeneity of double cortex syndrome. Ann Neurol 2000;47:265-9.
82. Leventer RJ, Pilz DT, Matsumoto N, et al. Lissencephaly and subcortical band heterotopia: Molecular basis and diagnosis. Mol Med Today 2000;6:277-84.
83. Matsumoto N, Leventer RJ, Kuc J, et al. Mutation analysis of the DCX gene and genotype/phenotype correlation in subcortical band heterotopia. Eur J Hum Genet 2000;9(1):5-12.
84. Dobyns WB, Truwit CL, Ross ME, et al. Differences in the gyral pattern distinguish chromosome 17-linked and X-linked lissencephaly. Neurology 1999;53:270-7.
85. Gleeson JG, Allen KM, Fox JW, et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998;92:63-72.
86. Palmini A, Andermann F, Aicardi J, et al. Diffuse cortical dysplasia, or the "double cortex syndrome": The clinical and epileptic spectrum in 10 patients. Neurology 1991;41:1656-62.
87. Hong SE, Shugart YY, Huang DT, et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 2000;26:93-6.
88. Fukuyama Y, Ohsawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathologic considerations. Brain Dev 1981;3:1-29.
89. Takashima S, Becker L, Chan F, et al. A Golgi study of the cerebral cortex in Fukuyama-type congenital muscular dystrophy, Walker-type "lissencephaly," and classical lissencephaly. Brain Dev 1987;9:621-6.
90. Toda T, Miyake M, Kobayashi K, et al. Linkage-disequilibrium mapping narrows the Fukuyama-type congenital muscular dystrophy (FCMD) candidate region to less than 100 kb. Am J Hum Genet 1996;59:1313-20.
91. Toda T, Yoshioka M, Nakahori Y, et al. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome. Ann Neurol 1995;37:99-101.
92. Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998;394:388-92.
93. Worthington S, Turner A, Elber J, et al. 22q11 deletion and polymicrogyria - cause or coincidence? [In Process Citation]. Clin Dysmorphol 2000;9:193-7.
94. Leventer RJ, Lese CM, Cardoso C, et al. A study of 220 patients with polymicrogyria delineates distinct phenotypes and reveals genetic loci on chromosome 1p, 2p, 6q, 21q and 22q. Am J Hum Gen 2001;70(Suppl):Abstract.
95. Villard L, Nguyen K, Winter RM, et al. X-linked bilateral perisylvian polymicrogyria maps to Xq28. In Am J Hum Gen 2001;70(Suppl):Abstract.
96. Raymond AA, Fish D, Sisodiya S, et al. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: Clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995;118:629-60.